Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jun 29, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

New technologies in cervical cancer screening.

Patti E Gravitt¹, François Coutlée, Thomas Iftner

¹Departments of Epidemiology and Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. pgravitt@jhsph.edu

|October 14, 2008

Summary

Molecular cervical cancer screening offers improved detection and management. Rapid molecular tests are crucial for low-resource settings, enhancing screening effectiveness and reducing follow-up losses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Incidence and Prevalence of Human Papillomavirus Infection to Predict Outcomes from HPV-Based Cervical Cancer Screening in Women and People with a Cervix Living with HIV.

Journal of acquired immune deficiency syndromes (1999)·2026

Same author

HPV Prevalence Among Inuit Women in Northern Quebec, Canada: A Pre- and Post-Vaccination Analysis.

Journal of lower genital tract disease·2026

Same author

Benefit of BK Polyomavirus Screening in the First Year After Lung Transplantation.

Transplant international : official journal of the European Society for Organ Transplantation·2025

Same author

Impact of HPV vaccination on the incidence and clearance of HPV infections in sexually active young women.

Vaccine·2025

Same author

Protection Against Persistent HPV-16/18 Infection After Different Number of Doses of Quadrivalent Vaccine in Girls and Young Women: A Randomized Clinical Trial.

JAMA network open·2025

Same author

Human Papillomavirus Persistence, Recurrence, and Incidence in Early Childhood.

The Journal of infectious diseases·2025

Area of Science:

Oncology
Molecular Diagnostics
Public Health

Background:

Cervical cancer screening faces challenges in both developed and developing nations.
Current screening methods often lack sufficient specificity, leading to over-management.
Loss to follow-up significantly hinders screening program effectiveness, particularly in low-resource areas.

Purpose of the Study:

To explore the potential of molecular approaches for advancing cervical cancer screening.
To identify screening technologies that can improve positive predictive value and specificity.
To highlight the role of rapid molecular tests in resource-limited settings.

Main Methods:

The study reviews the current landscape and future directions of cervical cancer screening technologies.

More Related Videos

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

Related Experiment Videos

Last Updated: Jun 29, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

It emphasizes the shift towards molecular-based diagnostics.

The impact of rapid testing in different healthcare settings is discussed.

Main Results:

A molecular approach is identified as the most promising solution for improved cervical cancer screening globally.
Rapid molecular tests show significant potential for immediate results, addressing follow-up issues.
These tests are particularly beneficial for low and middle-income countries and underserved populations.

Conclusions:

Molecular diagnostics represent the future of cervical cancer screening.
Rapid molecular tests are essential for overcoming barriers in resource-limited settings.
Further clinical validation is necessary before widespread implementation of rapid molecular screening tests.